Main description:

This collection of chapters describes in detail the latest insights into the evaluation of resectability and neoadjuvant therapy to pancreaticoduodenectomy and distal pancreatectomy for pancreatic cancer. Shedding light on immunotherapy and gene therapy, this volume comprehensively covers treatments and procedures for the disease, allowing surgeons and trainees to gain an overview and explore innovative treatments. It also provides information on various cases using tools such as endoscopic ultrasound, MDCT, PET for diagnosis and laparoscopy and robotic resection methods. Edited and authored by pioneering professionals, Diagnosis and Treatment for Pancreatic Cancer is a valuable resource for gastroenterologists, medical oncologists, surgical oncologist and general surgeons interested in treatment of pancreatic cancer care.

Contents:

Part1: Diagnosis of Pancreatic Cancer 1 Early diagnosis for pancreatic cancer using endoscopic ultrasound2 Evaluation of resectability for pancreatic cancer using endoscopic ultrasound3 Evaluation of resectability for pancreatic cancer by MDCT before and after neoadjuvant therapy4 Evaluation of effect of neoadjuvant therapy using positron emission tomography5 Liquid biopsy for early diagnosis of pancreatic cancerPart 2: The Indication and Procedure of Pancreaticoduodenectomy for Pancreatic Cancer 6 Panceraticoduodenectomy- standard resection and extended resection-7 ;Pylorus resecting panceraticoduodenectomy8 Pancreaticoduodenectomy with portal vein resection9 Pancreaticoduodenectomy with main vascular resection10 Laparoscopic pancreaticoduodenectomy11 Robotic pancreaticoduodenectomyPart 3: The Indication and Procedure of Distal Pancreatectomy 12 Distal pancreatectomy for pancreatic carcinoma13 Distal pancreatectomy with celiac axis en-bloc resection (DP-CAR) for pancreatic carcinoma14 Modified DP-CAR for pancreatic carcinoma15 Laparoscopic distal pancreatectomyPart 4: Immunnotherapy, Gene Therapy for Pancreatic Cancer 16 Development of Cancer Vaccine and Targeted Immune Checkpoint Therapies 17 Development of Hypoxia-activated, cytotoxic prodrug 18 Oncolytic virotherapy